Skip to Content

Rabies immune globulin, human Pregnancy and Breastfeeding Warnings

Rabies immune globulin, human is also known as: Bayrab, Hyperab, Imogam Rabies-HT

Rabies immune globulin, human Pregnancy Warnings

Animal studies have not been conducted. There are no controlled data in human pregnancy. Clinical experience with immunoglobulins suggests that no harmful effects on the course of pregnancy, the fetus, or the neonate are to be expected. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Use is not recommended unless clearly needed. AU TGA pregnancy category: Not formally assigned to a pregnancy category. US FDA pregnancy category: C

See references

Rabies immune globulin, human Breastfeeding Warnings

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Unknown

The World Health Organization (WHO) considers rabies immunoglobulin compatible with breastfeeding.

See references

References for pregnancy information

  1. "Product Information. Hyperrab S/D (rabies immune globulin, human)." Grifols Therapeutics, Clayton, NC.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  4. "Product Information. Imogam Rabies-HT (rabies immune globulin, human)." sanofi pasteur, Swiftwater, PA.

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Hyperrab S/D (rabies immune globulin, human)." Grifols Therapeutics, Clayton, NC.
  4. Department of Adolescent and Child Health and Development. UNICEF. World Health Organization "Breastfeeding and maternal medication: recommendations for drugs in the eleventh Who model list of essential drugs. Available from: URL: http://whqlibdoc.who.int/hq/2002/55732.pdf?ua=1" ([2003]):
  5. "Product Information. Imogam Rabies-HT (rabies immune globulin, human)." sanofi pasteur, Swiftwater, PA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide